Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Business
Nils Pratley

A quiet conspiracy is afoot to give FTSE 100 executives a pay rise

Pascal Soriot
Pascal Soriot, the chief executive of AstraZeneca. The value of his overall annual reward could be as high as £25.2m. Photograph: Sophia Evans/The Observer

It seems the UK financial and corporate establishment is agreed. The London stock market is in a funk, with too many companies hopping off to re-list in New York. Therefore the UK executive class must be given US-style pay packages to keep ‘em loyal.

That’s a slight exaggeration since, so far, it’s only a handful of companies – the likes of AstraZeneca, HSBC, LSEG (the owner of the London Stock Exchange) and the medical devices group Smith & Nephew – that have revealed, or signalled, that they want to boost executive rewards to keep up with US rivals. And none of them have threatened to quit London. All the same, it’s remarkable that an intense debate about the woes of the London stock market has morphed into a refrain about executive pay in the UK.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.